Abstract:485 Background: To evaluate the prevalence and prognostic value of variant histology in urinary tract tumors according to primary location and metastatic status. Methods: Using the Surveillance, Epidemiology, and End Results registry (SEER, 2004-2015) databases, patients with urinary tract tumors were identified. Propensity Score Matching was used to balance the clinicopathologic features between different histologies. Kaplan-Meier plots were used to compare the cancer specific survival (CSS) and overall survival (OS) of different histologies. The cox regression analysis were also applied. Results: Of all 93,200 eligible patients with urinary tract tumors, 87,323 (93.7%) harbored bladder cancer (3,685 in M1 stage). Among them, urothelial tumors (UC) accounted for 96.67%, followed by squamous neoplasm (SCC), urachal carcinoma (Urachal), adenocarcinoma (Adeno), neuroendocrine tumors (NE) and tumor of Müllerian type (Müllerian). A total of 5877 (6.35%) harbored upper urinary tract tumors (950 in M1 stage). Among them, UC accounted for 96.39%, followed by SCC, Urachal, Müllerian, NE, Adeno. In patients with localized diseases, those with non-urothelial tumors had significantly worse prognosis in overall urinary tract tumors based on OS and CSS (P<0.001). In terms of specific histology in bladder cancer (BC), patients with UC had most favorable prognosis, followed by Adeno, Urachal and Müllerian, while those with SCC and NE were associated with the worst survival outcomes. In patients with upper urinary tract tumors (UUTT), those with Müllerian had the best survival outcomes, followed by UC, while those with NE, Adeno, SCC, and Urachal had relatively worse prognosis. In M1 stage, although there was a statistical difference in OS and CSS between all patients with urothelial and non-urothelial tumors (P<0.001), the 5-year survival rate (3.74%, 2.50%) and 5-year CSM (4.93%, 3.28%) were similar. In metastatic BC, there was no difference in OS among all histology. However, in terms of CSS, significant differences were still observed in patients with different histologies. In metastatic UUTT, no difference in survival was found among different histologies. After PSM, the similar results were observed in BC, while there is no statistical difference of survival among different histologies in UUTT, no matter the M stage. Cox analyses revealed that primary location, histology type, surgery, chemotherapy and M stage were the common and strong independent prognostic factors in both BC and UUTT. Conclusions: In urinary tract tumors, the incidence of different histology types between BC and UUTT is roughly similar. Overall, patient with variant histology have a worse prognosis than those with urothelial carcinoma. However, differences in survival among the histology types vary by primary location and metastatic status, especially the metastatic status.

Sensitivity of Initial Biopsy or Transurethral Resection of Bladder Tumor(s) for Detecting Histological Variants on Radical Cystectomy

Survival of Patients With UrAC and Primary BAC and Urothelial Carcinoma With Glandular Differentiation

Impact of variant histology on upstaging and survival in patients with nonmuscle invasive bladder cancer undergoing radical cystectomy

Survival Impact of Variant Histology in Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy.

Occurrence and prognostic significance of different histology relative to urinary tract tumors: A SEER population-based study.

Prevalence and Prognostic Significance of Histologic Subtypes in Urinary Tract Tumors: A SEER Population-Based Study

Effect of Concomitant Variant Histology on the Prognosis of Patients with Upper Urinary Tract Urothelial Carcinoma after Radical Nephroureterectomy.

Variant histology is associated with more non‐urothelial tract recurrence but less intravesical recurrence for upper tract urothelial carcinoma after radical nephroureterectomy

Intravesical Recurrence after Radical Nephroureterectomy of Upper Urinary Tract Urothelial Carcinoma: A Large Population-Based Investigation of Clinicopathologic Characteristics and Survival Outcomes.

Squamous Differentiation in Patients with Superficial Bladder Urothelial Carcinoma is Associated with High Risk of Recurrence and Poor Survival

Detection and resection of carcinoma in situ of the bladder: Implications for clinical trial design

Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma

Impact of Squamous And/or Glandular Differentiation on Recurrence and Progression Following Transurethral Resection for Non-Muscle Invasive Urothelial Carcinoma of Bladder

Squamous Differentiation in Pt1 Bladder Urothelial Carcinoma Predicts Poor Response for Intravesical Chemotherapy.

Diagnostic and Prognostic Role of BTA, NMP22, Survivin and Cytology in Urothelial Carcinoma.

Non-muscle invasive high grade urothelial carcinoma of the bladder. Which factors can influence understaging at the time of radical cystectomy?

Impact of Preoperative Diagnostic TURBT on Progression-Free Survival in Patients with Pathological High-Grade, Stage T3/T4 Bladder Urothelial Carcinoma

Variant histology in upper tract carcinomas: Analysis of the National Cancer Database

Clinical Characteristics and Prognosis of Rare Histological Variants of Bladder Cancer: A Single-Center Retrospective Study from China.

Impact of Squamous Differentiation on Intravesical Recurrence and Prognosis of Patients with Upper Tract Urothelial Carcinoma.

Clinical Significance of Radical Cystectomy with Extended Lymphadenectomy